Variables | Non-psoriasis group | Psoriasis group | Compared to non-psoriasis group | |||||
---|---|---|---|---|---|---|---|---|
HR (95% CI) | ||||||||
Event no. | Person-year | IR | Event no. | Person-year | IR | Crude | Adjusteda | |
Sex | ||||||||
 Women | 71 | 25,959 | 2.74 | 20 | 6551 | 3.05 | 1.11 (0.68–1.83) | 1.07 (0.65–1.77) |
 Men | 55 | 29,488 | 1.87 | 30 | 7407 | 4.05 | 2.17 (1.39–3.39)*** | 2.05 (1.31–3.20)** |
Age, years | ||||||||
 20–39 | 48 | 25,231 | 1.90 | 14 | 6368 | 2.20 | 1.16 (0.64–2.10) | 1.16 (0.64–2.11) |
 40–59 | 44 | 19,182 | 2.29 | 16 | 4792 | 3.34 | 1.46 (0.82–2.58) | 1.26 (0.71–2.45) |
 ≥ 60 | 34 | 11,034 | 3.08 | 20 | 2797 | 7.15 | 2.32 (1.34–4.04)** | 2.32 (1.33–4.06)** |
Comorbidity statusb | ||||||||
 No | 63 | 41,393 | 1.52 | 23 | 9278 | 2.48 | 1.63 (1.01–2.63)* | 1.66 (1.03–2.67)* |
 Yes | 63 | 14,054 | 4.48 | 27 | 4680 | 5.77 | 1.29 (0.82–2.02) | 1.29 (0.82–2.03) |